Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

17 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Real-World Tumor Response of Palbociclib in Combination With an Aromatase Inhibitor as First-Line Therapy in Pre/Perimenopausal Women With Metastatic Breast Cancer.
DeMichele A, Robert N, Chen C, Kim S, Zhang Z, Lu DR, Aguilar KM, Wang Y, Li B, Schneeweiss S, Rassen JA, Gaffney M, McRoy L. DeMichele A, et al. Among authors: aguilar km. Target Oncol. 2023 Jul;18(4):543-558. doi: 10.1007/s11523-023-00979-1. Epub 2023 Jul 10. Target Oncol. 2023. PMID: 37428347 Free PMC article.
Treatment patterns and clinical outcomes in patients with advanced non-small cell lung cancer initiating first-line treatment in the US community oncology setting: a real-world retrospective observational study.
Nadler E, Arondekar B, Aguilar KM, Zhou J, Chang J, Zhang X, Pawar V. Nadler E, et al. Among authors: aguilar km. J Cancer Res Clin Oncol. 2021 Mar;147(3):671-690. doi: 10.1007/s00432-020-03414-4. Epub 2020 Dec 2. J Cancer Res Clin Oncol. 2021. PMID: 33263865 Free PMC article.
Treatment Sequencing Patterns in Patients with Metastatic Urothelial Cancer Treated in the Community Practice Setting in the United States: SPEAR-Bladder (Study informing treatment Pathway dEcision in bladder cAnceR).
Doshi GK, Bhanegaonkar A, Kearney M, Bharmal M, Cislo P, Kim R, Boyd M, Aguilar KM, Phatak H. Doshi GK, et al. Among authors: aguilar km. Clinicoecon Outcomes Res. 2020 Nov 5;12:645-656. doi: 10.2147/CEOR.S264942. eCollection 2020. Clinicoecon Outcomes Res. 2020. PMID: 33192078 Free PMC article.
An observational study of drug utilization and associated outcomes among adult patients diagnosed with BRAF-mutant advanced melanoma treated with first-line anti-PD-1 monotherapies or BRAF/MEK inhibitors in a community-based oncology setting.
Cowey CL, Boyd M, Aguilar KM, Beeks A, Krepler C, Scherrer E. Cowey CL, et al. Among authors: aguilar km. Cancer Med. 2020 Nov;9(21):7863-7878. doi: 10.1002/cam4.3312. Epub 2020 Sep 1. Cancer Med. 2020. PMID: 32871054 Free PMC article.
17 results